Novartis Chief Executive Joseph Jimenez will retire in 2018, with chief drug developer Vasant Narasimhan taking over as CEO starting in February, the Swiss drugmaker said on Monday. Jimenez is stepping down following a decade at Novartis after having successfully secured U.S. approval for a new gene therapy for leukemia last week but before Novartis […]
Read moreAs the U.S. mulls its next move against North Korea, some have suggested that sanctioning the major Chinese banks could be the most effective way to pressure the rogue nation into halting its nuclear program. Targeting the big lenders from the world’s second-largest economy is not a new idea. And it would not necessarily just […]
Read moreEuropean markets were set to open lower on Monday morning, as North Korea’s latest nuclear test prompted investors to rush to safe-haven assets. The FTSE 100 is seen 19 points lower at 7,426; the Dax is expected to open down by 59 points at 12,083 and the CAC 40 is set to open 23 points […]
Read moreChina should stop exporting crude oil to North Korea after the reclusive nation defied the international community by testing a nuclear bomb on Sunday despite numerous international trade sanctions, experts told CNBC. “If China decides to cut off that vital supply of crude oil going to North Korea, there will be an immediate and pretty […]
Read morePresident Donald Trump is set to scrap an Obama-era program this week that protects people who entered the United States illegally as children, according to multiple reports. Politico, citing sources, reported that Trump was persuaded to terminate the Deferred Action for Childhood Arrivals (DACA) program following conversations with Attorney General Jeff Sessions. Reuters also reported, […]
Read more